About Rytus Therapeutics Limited
Data last updated:
Rytus Therapeutics Limited is a public limited company based in Thane, Maharashtra, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 February 2011.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PLC213828. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹6.25 Cr and a paid-up capital of ₹6.21 Cr. It is led by directors including Anand Mohanty Swaroop (Whole-Time Director) and Atul Laxmichand Gala (Irp/Rp/Liquidator).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 1601 16th Floor Willowcrest Building One Hiranandani Park, Thane, Maharashtra.
As per the financials filed for FY 2015, the company reported a revenue of ₹1.42 Cr, a growth of 63% compared to the previous year. For the same year it recorded a net loss of ₹2.87 Cr (net margin -202.4%) and EBITDA of -₹1.72 Cr (EBITDA margin -121%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
As per MCA filings, the company has satisfied charges of ₹1.85 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The last known website on record is rytus.in.
Company details
Contact details
Rytus Therapeutics Limited's registered office is in Thane, Maharashtra. Its website is rytus.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressFlat No.1601 16th Floor Willowcrest Building One Hiranandani Park Ghodbunder Road Th, Ane West, Thane, Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rytus Therapeutics Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rytus Therapeutics Limited
FY 2023 filings availableRytus Therapeutics Limited reported revenue of ₹1.42 Cr (up 63% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue rose 63% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 6%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | ₹1.42 Cr |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹1.72 Cr |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹2.87 Cr |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | -121% |
| Net Profit Margin | -202.4% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Rytus Therapeutics Limited, buy the company report.
Board of directors of Rytus Therapeutics Limited
Rytus Therapeutics has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Mohanty Swaroop | Whole-Time Director | 21 Feb 2011 | 15 Years 8 Months | As last reported |
| Atul Laxmichand Gala Also directs: Virtuoso Ipe Private Limited | Irp/Rp/Liquidator | 24 Jun 2024 | 2 Years 4 Months | As last reported |
| Abhinna Mohanty Sundar | Director | 21 Feb 2011 | 15 Years 8 Months | As last reported |
| Manas Ranjan Patnaik Also directs: Candaur Pharmaceuticals Private Limited | Additional Director | 01 Dec 2021 | 4 Years 10 Months | As last reported |
Auditor
Rytus Therapeutics Limited is audited by N K MITTAL & ASSOCIATES for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N K MITTAL & ASSOCIATES | FY 2015 | 113281W |
Shareholding
The shareholding of Rytus Therapeutics Limited is on record for FY 2015, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2015 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rytus Therapeutics Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Feb 2013 | 10408148 | Axis Bank Limited | ₹1.1 Cr | Satisfied | |
| 05 Oct 2011 | 10313207 | Tamilnad Mercantile Bank Limited | ₹75 Lakh | Satisfied |
To see the full charge records of Rytus Therapeutics Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Rytus Therapeutics Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by RBL Bank Ltd. | Disposed |
To see the full case history of Rytus Therapeutics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rytus Therapeutics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rytus Therapeutics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rytus Therapeutics Limited, buy the company report.
Recent activity
Rytus Therapeutics Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Atul Laxmichand Gala was appointed as Irp/Rp/Liquidator on 24 Jun 2024.
4 earlier events are in the company report.
Frequently asked questions
Rytus Therapeutics is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Rytus Therapeutics is a company under insolvency, formerly operating as a public limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 February 2011 and is registered under CIN U24100MH2011PLC213828. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Rytus Therapeutics has 4 current directors:
- Anand Mohanty Swaroop - Whole-Time Director
- Abhinna Mohanty Sundar - Director
- Manas Ranjan Patnaik - Additional Director
- Atul Laxmichand Gala - Irp/Rp/Liquidator
The latest financial statements of Rytus Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rytus Therapeutics is U24100MH2011PLC213828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rytus Therapeutics has no open charges and satisfied charges of ₹1.85 Cr as per latest MCA filings.
Rytus Therapeutics has 2 court cases on record: 2 filed against it.
Rytus Therapeutics was incorporated on 21 February 2011. It is registered with the Registrar of Companies, Mumbai.
Atul Laxmichand Gala was appointed as Irp/Rp/Liquidator on 24 Jun 2024. Manas Ranjan Patnaik was appointed as Additional Director on 01 Dec 2021. Supriya Mohanty ceased to be Director on 01 Dec 2021. Rytus Therapeutics has 7 board changes on record in total.
Rytus Therapeutics can be reached through the website rytus.in. Its registered office is in Thane, Maharashtra, India.